These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 20585151

  • 21. Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells.
    McCarron PA, Marouf WM, Quinn DJ, Fay F, Burden RE, Olwill SA, Scott CJ.
    Bioconjug Chem; 2008 Aug; 19(8):1561-9. PubMed ID: 18627195
    [Abstract] [Full Text] [Related]

  • 22. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
    Yallapu MM, Gupta BK, Jaggi M, Chauhan SC.
    J Colloid Interface Sci; 2010 Nov 01; 351(1):19-29. PubMed ID: 20627257
    [Abstract] [Full Text] [Related]

  • 23. Selectivity of folate conjugated polymer micelles against different tumor cells.
    Zhao H, Yung LY.
    Int J Pharm; 2008 Feb 12; 349(1-2):256-68. PubMed ID: 17850996
    [Abstract] [Full Text] [Related]

  • 24. Improved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinoma.
    Liang C, Yang Y, Ling Y, Huang Y, Li T, Li X.
    Bioorg Med Chem; 2011 Jul 01; 19(13):4057-66. PubMed ID: 21641806
    [Abstract] [Full Text] [Related]

  • 25. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
    Chung YI, Kim JC, Kim YH, Tae G, Lee SY, Kim K, Kwon IC.
    J Control Release; 2010 May 10; 143(3):374-82. PubMed ID: 20109508
    [Abstract] [Full Text] [Related]

  • 26. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V.
    J Control Release; 2009 Jan 05; 133(1):11-7. PubMed ID: 18950666
    [Abstract] [Full Text] [Related]

  • 27. 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitro.
    Han X, Liu J, Liu M, Xie C, Zhan C, Gu B, Liu Y, Feng L, Lu W.
    Int J Pharm; 2009 May 08; 372(1-2):125-31. PubMed ID: 19166923
    [Abstract] [Full Text] [Related]

  • 28. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
    Prabaharan M, Grailer JJ, Pilla S, Steeber DA, Gong S.
    Biomaterials; 2009 Oct 08; 30(30):6065-75. PubMed ID: 19674777
    [Abstract] [Full Text] [Related]

  • 29. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L, Li F, Zhang H, Wang Y, Cheng C, Li X, Gu CH, Yang Q, Wu H, Zhang S.
    Biomaterials; 2010 Jul 08; 31(21):5634-42. PubMed ID: 20430433
    [Abstract] [Full Text] [Related]

  • 30. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
    Lin JJ, Chen JS, Huang SJ, Ko JH, Wang YM, Chen TL, Wang LF.
    Biomaterials; 2009 Oct 08; 30(28):5114-24. PubMed ID: 19560199
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
    Lale SV, R G A, Aravind A, Kumar DS, Koul V.
    Biomacromolecules; 2014 May 12; 15(5):1737-52. PubMed ID: 24689987
    [Abstract] [Full Text] [Related]

  • 33. Targeting of nanoparticles: folate receptor.
    Kularatne SA, Low PS.
    Methods Mol Biol; 2010 May 12; 624():249-65. PubMed ID: 20217601
    [Abstract] [Full Text] [Related]

  • 34. Folate mediated histidine derivative of quaternised chitosan as a gene delivery vector.
    Morris VB, Sharma CP.
    Int J Pharm; 2010 Apr 15; 389(1-2):176-85. PubMed ID: 20117198
    [Abstract] [Full Text] [Related]

  • 35. Receptor-mediated cellular uptake of folate-conjugated fluorescent nanodiamonds: a combined ensemble and single-particle study.
    Zhang B, Li Y, Fang CY, Chang CC, Chen CS, Chen YY, Chang HC.
    Small; 2009 Dec 15; 5(23):2716-21. PubMed ID: 19743434
    [Abstract] [Full Text] [Related]

  • 36. The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.
    Hong S, Leroueil PR, Majoros IJ, Orr BG, Baker JR, Banaszak Holl MM.
    Chem Biol; 2007 Jan 15; 14(1):107-15. PubMed ID: 17254956
    [Abstract] [Full Text] [Related]

  • 37. Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells.
    Li P, Wang Y, Zeng F, Chen L, Peng Z, Kong LX.
    Carbohydr Res; 2011 May 01; 346(6):801-6. PubMed ID: 21397214
    [Abstract] [Full Text] [Related]

  • 38. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
    Yin Y, Chen D, Qiao M, Lu Z, Hu H.
    J Control Release; 2006 Dec 01; 116(3):337-45. PubMed ID: 17097180
    [Abstract] [Full Text] [Related]

  • 39. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.
    Ulbrich K, Michaelis M, Rothweiler F, Knobloch T, Sithisarn P, Cinatl J, Kreuter J.
    Int J Pharm; 2011 Mar 15; 406(1-2):128-34. PubMed ID: 21185364
    [Abstract] [Full Text] [Related]

  • 40. Anti-CD8 conjugated nanoparticles to target mammalian cells expressing CD8.
    Bicho A, Peça IN, Roque AC, Cardoso MM.
    Int J Pharm; 2010 Oct 31; 399(1-2):80-6. PubMed ID: 20696228
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.